Cases 81 - 90 of 416
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. HETERO USA INC. et al
as 1:2022cv01795
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
HETERO USA INC., HETERO LABS LIMITED and HETERO LABS LIMITED UNIT-III
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MATHIS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01246
Plaintiff:
BENNY MATHIS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Edward Gramza v. Zhejiang HuaHai Pharmaceutical Co., Ltd., et al
as 1:2022cv00956
Plaintiff:
EDWARD GRAMZA, ADM. OF THE ESTATE OF BRIAN GRAMZA, DECEASED, and Edward Gramza
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., a foreign corporation, HUAHAI US, INC., a foreign corporation, PRINSTON PHARMACEUTICAL, INC., a foreign corporation and others
Cause Of Action: 28 U.S.C. § 1441 Petition for Removal
POMA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01118
Defendant:
FRANCESCO POMA, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GRUBB et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00918
Plaintiff:
ESTATE OF DUDLEY WAYNE GRUBB and TERESA A. GRUBB
Defendant:
AUROBINDO PHARMA, LTD., ARROW PHARMA (MALTA) LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GALLAGHER v. HETERO DRUGS, LTD. et al
as 1:2022cv00930
Plaintiff:
KELLY GALLAGHER
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, HETERO DRUGS, LTD., HETERO LABS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SMOOT v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00285
Plaintiff:
LEE ESTHER SMOOT
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BRANCH v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00582
Plaintiff:
TERRELL BRANCH
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
